IRADIMED CORPORATION Deferred Federal Income Tax Expense (Benefit)
IRADIMED CORPORATION (IRMD) reported Deferred Federal Income Tax Expense (Benefit) of $2.53 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-06
- IRADIMED CORPORATION deferred federal income tax expense (benefit) for fiscal 2025 was $2.53M.
- IRADIMED CORPORATION deferred federal income tax expense (benefit) for fiscal 2024 was -$596.00K.
- IRADIMED CORPORATION deferred federal income tax expense (benefit) for fiscal 2023 was -$1.20M.
- IRADIMED CORPORATION deferred federal income tax expense (benefit) for fiscal 2022 was -$105.07K, a 126.30% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.53M 10-K · filed 2026-03-06 | |
| 2024-12-31 | -$596.00K 10-K · filed 2026-03-06 | -$595.88K 10-K · filed 2025-03-06 |
| 2023-12-31 | -$1.20M 10-K/A · filed 2025-09-03 | |
| 2022-12-31 | -$105.07K 10-K · filed 2024-03-01 | |
| 2021-12-31 | $399.51K 10-K · filed 2023-03-02 | |
| 2020-12-31 | $547.20K 10-K · filed 2022-03-04 | $547.20K 10-K · filed 2021-03-05 |
| 2019-12-31 | -$544.38K 10-K · filed 2022-03-04 | |
| 2018-12-31 | -$128.91K 10-K · filed 2021-03-05 | |
| 2017-12-31 | -$92.79K 10-K · filed 2020-03-06 | |
| 2016-12-31 | -$509.40K 10-K · filed 2019-03-07 | |
| 2015-12-31 | -$13.17K 10-K · filed 2018-03-08 | |
| 2014-12-31 | -$149.25K 10-K · filed 2017-03-10 | |
| 2013-12-31 | -$14.28K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |